New Oncologists Boost Local Cancer Care in Palm Beach and Central Florida

21020 State Road 7, Ste. 200C, Boca Raton, FL 33428, USA - The growing demand for enhanced cancer care in Florida has prompted the Florida Cancer Specialists & Research Institute (FCS) to bolster its services by welcoming two accomplished medical oncologists. Dr. Marisabel H. Castillo will join the ranks in Palm Beach County, while Dr. Roderick Paras is set to make his mark in Central Florida. This addition is expected to strengthen local access to cancer care just when it’s needed the most.

Dr. Castillo is ready to bring her expertise to the community at the FCS Boca Raton clinic and the nearby FCS Delray Beach clinic. A graduate of the Central University of Venezuela, she has received accolades such as the Outstanding Continuity Clinic Resident Award from New York University. Her impressive academic journey also includes a prestigious role as chief fellow during her hematology/medical oncology fellowship at the University of Texas at Austin. Dr. Castillo has dedicated much of her career to clinical research focused on immunotherapies and strategies aimed at reducing disparities in cancer diagnosis and treatment.

A New Era for Cancer Treatment

Meanwhile, Dr. Paras will be providing care at several FCS cancer centers across Lake Mary, Deland, and Orange City. His medical degree from the University of Santo Tomas in Manila, combined with an internal medicine residency at New York Medical College’s St. Vincent’s Medical Center, equips him well for this role. Dr. Paras also completed a fellowship in medical oncology at the Medical College of Pennsylvania in Pittsburgh. FCS President & Managing Physician Lucio N. Gordan, MD, commended Dr. Paras for his unwavering commitment to patient-centered care.

The expansion of the FCS team coincides with a significant period of advancement in the field of oncology. Cancer, which accounts for nearly 10 million deaths annually, remains a serious global health concern. However, the landscape of cancer care is transforming, largely due to significant advancements in cancer research over the past two decades. As highlighted by PubMed, these improvements have enhanced diagnosis, treatment, and even prevention strategies.

Personalized Medicine: The Future of Oncology

One of the key developments in modern cancer care is the shift towards personalized medicine. This approach integrates technological innovations with patient care, allowing for more precise and individualized treatment plans. Recent studies underscore the growing importance of genomic technologies in tailoring cancer therapies, where insights into genetic mutations from next-generation sequencing (NGS) contribute significantly to treatment strategies.

As outlined in research from PMC, methods such as high-throughput sequencing not only help identify critical genetic variations but also enhance therapeutic efficacy while minimizing adverse effects. However, challenges persist, from treatment resistance to access disparities in healthcare. Yet, the continuous evolution of cancer treatment modalities, including immune checkpoint inhibitors and CAR-T cell therapy, hints at a brighter future for patients navigating their cancer journeys.

FCS, with over 40 years of experience in oncology and a robust clinical research program, plays a pivotal role in this ongoing transformation. The institution emphasizes precision oncology advancements, allowing them to deliver tailored treatment plans aimed at improving patient outcomes. Dr. Castillo and Dr. Paras will undoubtedly contribute to this area, leveraging their wealth of knowledge to enhance the level of care available to Floridians.

As the need for innovative oncology solutions increases, Florida Cancer Specialists continues to pave the way by integrating cutting-edge research and a personalized approach to cancer care. With the addition of skilled oncologists like Dr. Castillo and Dr. Paras, local communities can look forward to enhanced access to high-quality cancer treatments and improved health outcomes.

For more detailed insights on the advancements in cancer treatment and the paradigm shift toward personalized medicine, you can read about it on PubMed and dive deeper into the technology driving this change at PMC.